Role of Tumor Microenvironment in Cancer Stem Cell and Clinical Application |Biomedgrid
Journal: American Journal of Biomedical Science & Research (Vol.15, No. 6)Publication Date: 2022-03-17
Authors : Angel Wang;
Page : 639-648
Keywords : Cancer stem cell; Tumor Microenvironment; Hypoxia; Cancer-associated fibroblasts; Immune cells;
Abstract
Cancer stem cells can differentiate and self-renew. Therefore, they are resistant to traditional therapies and cause cancer relapse. The most determinant factor for the CSCs resistance is the tumor microenvironment, which contains many aspects to prevent CSCs from being eradicated. In this review, we will introduce different aspects according to the tumor microenvironment (TME) like hypoxia, which allows CSCs to flourish in the TME; CAF, which contributes to the self-renewal quality of CSCs; immune cells, which could potentially incapacitate cancer cells and decrease the stemness of CSCs, and different major signaling pathways that help with the proliferation and survival of CSCs. We also conclude with the major clinical trials involved in each of the signaling pathways, which presents possibilities to assist with therapy.
Other Latest Articles
- Review: Communicating Public Health Intervention to Newcomers to Canada |Biomedgrid
- TB Diagnostics: Existing Platform and Future Direction |Biomedgrid
- Uvular Necrosis from a Traumatic Bronchoscopy |Biomedgrid
- Antioxidant Activity of Single Black Garlic (Allium sativum L.) Ethanol Extract and Its Potential for Oral and Dental Health
- PROFILE OF CUSTOMER SATISFACTION LEVEL WITH SELF-MEDICATION SERVICES AT PADANG GUCI 2 PHARMACY, BENGKULU CITY
Last modified: 2024-02-08 21:32:44